Artelo Biosciences to Present at the Annual Investival Showcase in London

LA JOLLA, Calif., Nov. 14, 2019 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company developing therapeutics that modulate the endocannabinoid system, today announced that it will be presenting at the Annual Investival Showcase to be held on November 19, 2019 at the Waldorf Hilton Hotel in London, England.